Core Scientific upgraded on its uncontracted power capacity
Affected assets and topics
Why it matters
Roth MKM upgraded Core Scientific to Buy, expecting the merger with CoreWeave to be rejected without renegotiation, citing growing shareholder opposition and proxy advisers' recommendations against the deal.
Article tone
Expected market reaction
Positive, as the upgrade and increased price target of $23.50 may lead to a short-term increase in Core Scientific's stock price, potentially benefiting investors who hold the stock.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 1597
Original source
Investing.com --Roth MKM upgraded Core Scientific to Buy saying it now expects the data center operator’s merger with CoreWeave to be rejected without renegotiation and sees value in its uncontracted power capacity.Roth lifted its price target to $23.50 from $17. There is growing shareholder opposition against deal and CoreWeave’s insistence that its offer was “best and final” have made the deal unlikely to close. Proxy advisers Glass Lewis and ISS have also recommended against it. The firms are
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on October 23, 2025. Analysis and insights provided by AnalystMarkets AI.